OBJECTIVES: To evaluate the prevalence and factors associated with statin pharmacotherapy in long-stay nursing home residents with life-limiting illness. DESIGN: Cross-sectional. SETTING: US Medicare- and Medicaid-certified nursing home facilities. PARTICIPANTS: Long-stay nursing home resident Medicare fee-for-service beneficiaries aged 65 years or older with life-limiting illness (n = 424 212). MEASUREMENTS: Prevalent statin use was estimated as any low-moderate intensity (daily dose low-density lipoprotein-cholesterol [LDL-C] reduction \u3c 30%-50%) and high-intensity (daily dose LDL-C reduction \u3e 50%) use via Medicare Part D claims for a prescription supply on September 30, 2016, with a 90-day look-back period. Life-limiting illness w...
BACKGROUND/OBJECTIVES: Overall and long-term opioid use among older adults have increased since 1999...
OBJECTIVE: To determine the effects of lipid-lowering agent (LLA) class and drug plan design option ...
Background: At the end of life goals of care change from disease prevention to symptomatic control, ...
OBJECTIVES: To evaluate the prevalence and factors associated with statin pharmacotherapy in long-st...
BACKGROUND: Medically compromised nursing home residents continue to be prescribed statins, despite ...
Background: Statins have questionable benefits among older adults with life-limiting illness. Statin...
OBJECTIVES: To examine the variability of statin use among nursing home residents and prescribing ph...
Objectives: Studies examining the effects of statins after acute myocardial infarction (AMI) exclude...
BACKGROUND: Guidance from randomized clinical trials about the ongoing benefits of statin therapies ...
Background: Statins are progressively accepted as being associated with reduced mortality. However, ...
BACKGROUND: Little is known about trends in statin use in United States (US) nursing homes. OBJECTIV...
Background: Statin use in elderly individuals with life-limiting illness such as advanced dementia i...
Background: Little is known about trends in statin use in United States (US) nursing homes. Objectiv...
Purpose: Balancing medications that are needed and beneficial and avoiding medications that may be h...
Objective: To assess how lipid-lowering drugs (LLDs) are administered in the hospitalized patients a...
BACKGROUND/OBJECTIVES: Overall and long-term opioid use among older adults have increased since 1999...
OBJECTIVE: To determine the effects of lipid-lowering agent (LLA) class and drug plan design option ...
Background: At the end of life goals of care change from disease prevention to symptomatic control, ...
OBJECTIVES: To evaluate the prevalence and factors associated with statin pharmacotherapy in long-st...
BACKGROUND: Medically compromised nursing home residents continue to be prescribed statins, despite ...
Background: Statins have questionable benefits among older adults with life-limiting illness. Statin...
OBJECTIVES: To examine the variability of statin use among nursing home residents and prescribing ph...
Objectives: Studies examining the effects of statins after acute myocardial infarction (AMI) exclude...
BACKGROUND: Guidance from randomized clinical trials about the ongoing benefits of statin therapies ...
Background: Statins are progressively accepted as being associated with reduced mortality. However, ...
BACKGROUND: Little is known about trends in statin use in United States (US) nursing homes. OBJECTIV...
Background: Statin use in elderly individuals with life-limiting illness such as advanced dementia i...
Background: Little is known about trends in statin use in United States (US) nursing homes. Objectiv...
Purpose: Balancing medications that are needed and beneficial and avoiding medications that may be h...
Objective: To assess how lipid-lowering drugs (LLDs) are administered in the hospitalized patients a...
BACKGROUND/OBJECTIVES: Overall and long-term opioid use among older adults have increased since 1999...
OBJECTIVE: To determine the effects of lipid-lowering agent (LLA) class and drug plan design option ...
Background: At the end of life goals of care change from disease prevention to symptomatic control, ...